Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
omega 3 + nigella sativa oil + anise seed
- Development stage
- Unknown
- Lead developer
- Beni-Suef University
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This investigational combination therapy consists of omega-3 fatty acids, Nigella sativa oil (black seed oil), and anise seed. Developed by Beni-Suef University, it is being evaluated as a nutritional supplement-based approach to treat COVID-19. The primary active ingredient in Nigella sativa oil is thymoquinone, which is recognized for its anti-inflammatory and immunomodulatory properties. Omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), further contribute to the anti-inflammatory profile of the formulation. The combination is intended to boost the human immune system and regulate the inflammatory response in patients infected with SARS-CoV-2, potentially reducing mortality and improving clinical outcomes. It is typically administered orally in capsule form.
- Other names
- Omega 3/Nigella Sativa Oil/Anise seed capsuleOmega-3 and Thymoquinone SupplementationOmega3 and Thymoquinone SupplementationOmega 3 and Thymoquinone Supplementation
02
Targets
AKT (RAC-alpha serine/threonine-protein kinase)NF-κBAMPK (Adenosine monophosphate–activated protein kinase)PPARG (Peroxisome proliferator-activated receptor gamma)
Beyond the preview
Go deeper on omega 3 + nigella sativa oil + anise seed.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on omega 3 + nigella sativa oil + anise seed.